Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

Director Gilbert A. Fuller of USANA Health Sciences acquired 4,230 restricted stock units on May 20, 2025, according to a Form 4 filing with the SEC.

Summary

• Gilbert A. Fuller, a director of USANA Health Sciences Inc., reported a transaction on May 20, 2025.
• The transaction involved the acquisition of 4,230 restricted stock units, each representing a contingent right to receive one share of USNA common stock.
• These restricted stock units vest in four equal installments: 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
• Following the reported transaction, Fuller directly owns 4,230 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of restricted stock units by a director is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a multi-quarter performance expectation for USANA Health Sciences.

Industry Context

Insider transactions are closely monitored as indicators of management's perspective on the company's valuation and prospects within the health and wellness industry.

Comparison to Industry Standards

• Comparing insider activity at USANA to that of competitors like Herbalife Nutrition and Nu Skin Enterprises can provide insights into relative management confidence.
• Equity compensation is a common practice, so the vesting schedule and size of the grant should be compared to industry norms.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder sentiment.
• The vesting schedule may incentivize the director to focus on long-term value creation, benefiting shareholders.

Key Dates

Keywords

USANA Health Sciences, Director, Gilbert A. Fuller, Restricted Stock Units, Form 4, Beneficial Ownership, USNA